One-shot Sputnik Light authorized as standalone, booster vaccine in Argentina

New Delhi: The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) has announced that the Russian one-shot Sputnik Light vaccine against coronavirus has been approved by the Ministry of Health of Argentina as a standalone vaccine and a booster shot. Sputnik Light vaccine is based on human adenovirus serotype 26 which is the first component of the...
New Delhi: The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) has announced that the Russian one-shot Sputnik Light vaccine against coronavirus has been approved by the Ministry of Health of Argentina as a standalone vaccine and a booster shot.
Sputnik Light vaccine is based on human adenovirus serotype 26 which is the first component of the Sputnik V vaccine.
Read also: Sputnik Light approved as universal booster shot in UAE